Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul;12(7):e948.
doi: 10.1002/ctm2.948.

Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma

Luis Meza  1 , Ameish Govindarajan  1 , Matthew Feng  2 , Sumanta K Pal  1
Affiliations
Comment

Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma

Luis Meza et al. Clin Transl Med. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Figures

FIGURE 1
FIGURE 1
Summary of the study design
See this image and copyright information in PMC

Comment on

References

    1. Cancer of the Kidney and Renal Pelvis: Cancer Stat Facts. SEER. Accessed May 27, 2022. https://seer.cancer.gov/statfacts/html/kidrp.html
    1. Survival Rates for Kidney Cancer. Accessed May 27, 2022. https://www.cancer.org/cancer/kidney‐cancer/detection‐diagnosis‐staging/...
    1. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal‐Cell Carcinoma | NEJM. Accessed May 27, 2022. https://www.nejm.org/doi/full/10.1056/nejmoa1712126 - DOI - PMC - PubMed
    1. Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD‐1‐based immunotherapy against epithelial tumors. Science. 2018;359(6371):91‐97. 10.1126/science.aan3706 - DOI - PubMed
    1. Salgia NJ, Bergerot PG, Maia MC, et al. Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti‐PD‐1 immune checkpoint inhibitors. Eur Urol. 2020;78(4):498‐502. 10.1016/j.eururo.2020.07.011 - DOI - PubMed

MeSH terms